On July 12, the China Pharmaceutical and Health Industry Symbiosis Conference was held in Huzhou, Zhejiang Province, hosted by Guangzhou JD Pharmaceutical Information Co. and under the guidance of China Pharmaceutical Education Association, China Association of Non-prescription Drugs and China Pharmacists Association. At the conference, the five lists of " Top 100 China Pharmaceutical Industry 2021" was released based on innovation and profession for Chinese pharmaceutical industry enterprises.

As one of the leading forces in the biotechnology industry, Hybribio stood out with its excellent performance, innovative technology strength and strong sense of social responsibility, and was ranked in the "Top 20 China Medical Device Enterprises 2021" list.

The pursuit of the nation is the pursuit of Hybribio. Since the outbreak of the COVID-19 epidemic, Hybribio's 32 medical laboratories nationwide, which designated by the Health and Welfare Commission as the nucleic acid testing institutions, have fully participated in the battle against the epidemic. Till now, the Hybribio have participated in large-scale screenings for COVID-19 in nearly 50 cities, including Beijing, Shanghai, Guangdong and Hong Kong. By the end of July 2022, we have provided COVID-19 testing services for over 340 million people in total. Innovation is the core driving force for the development of biomedical and health industries. In 2022, Hybribio will continue to increase investment in R&D and focus on nucleic acid pathogen detection, genetic disease detection, respiratory tract infection detection, tumor and individualized medication guidance, with maternal and child health as the main focus. Hybribio products are widely used in hospital clinical diagnosis and mass population screening. The ranking of "Top 20 China Medical Device Enterprises" is another recognition of Hybribio's excellent performance in company operation and innovation development. In the future, Hybribio will continue to strengthen innovation and forge ahead by closely matching the actual needs of the national biomedical health development strategy, and contribute Hybribio's strength to the long-term development of China's biomedical health industry.

TOP 20 China Medical Device Enterprises 2021